UK Edition

Thursday, 5 November 2026

Markets Brief

News, business, world affairs and market coverage

Business

Galapagos NV Announces Gamgertamig Preliminary Phase 1b Data and Poster Presentation at 2026 ASH Meeting

Markets Brief gilt-and-policy note (2026-11-04): Galapagos NV announced the acceptance of a poster presentation at the 2026 American Society of Hematology Annual Meeting, scheduled for December 12-15,… Primary source: original at Nasdaq (nasdaq.com).

By Nasdaq

Galapagos NV Announces Gamgertamig Preliminary Phase 1b Data and Poster Presentation at 2026 ASH Meeting

Galapagos NV announced the acceptance of a poster presentation at the 2026 American Society of Hematology Annual Meeting, scheduled for December 12-15, featuring preliminary data for gamgertamig in relapsed/refractory autoimmune cytopenias. Gamgertamig is an investigational BCMAx

Read at source

Read also